$ERB 4-bagger rebuilding $3.75 called 9/7/13 $1.0
Post# of 63824
Posted On: 09/10/2014 5:12:54 PM
$ERB 4-bagger rebuilding $3.75
called 9/7/13 $1.02
Website
10-Q 8/12/14
Shares Outstanding: 43.88M
Float: 17.05M
100% Buy
Press Releases
Tuesday, August 12, 2014
ERBA Diagnostics Reports 2nd Quarter Financial Results; Consolidation, Operational Efficiencies, and Revenue Growth Increase Net Income by More Than 400%GlobeNewswire( (Tue, Aug 12)
Thursday, August 7, 2014
ERBA Diagnostics Schedules Conference Call to Discuss 2014 Second Quarter Financial ResultsGlobeNewswire
Monday, July 28, 2014
ERBA Diagnostics, Inc. to Exhibit at AACC 2014 in Chicago, USAGlobeNewswire
Friday, June 20, 2014
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and MarketingGlobeNewswire
Tuesday, May 27, 2014
ERBA Diagnostics, Inc. Appoints Mohan Gopalkrishnan as Chief Executive Officer and Prakash Patel as ControllerBusiness Wire
Wednesday, May 21, 2014
ERBA Diagnostics, Inc. Receives 510(K) Clearance for the XL200 Clinical Chemistry AnalyzerBusiness Wire
Thursday, May 15, 2014
ERBA Diagnostics, Inc. Reports First Quarter 2014 Financial ResultsBusiness Wire
Monday, April 14, 2014
ERBA Diagnostics, Inc. Reports 2013 Financial ResultsBusiness Wire
Thursday, April 10, 2014
ERBA Diagnostics, Inc. Announces Timeframe within Which It Intends to File Its Annual Report on Form 10-KBusiness Wire
Monday, March 31, 2014
ERBA Diagnostics, Inc. Announces Delay in Filing Annual Report on Form 10-KBusiness Wire
Wednesday, February 12, 2014
ERBA Diagnostics Inc. to Exhibit at Medlab Asia Pacific Singapore Feb 18-20, 2014Business Wire
Monday, January 13, 2014
ERBA Diagnostics, Inc. to Attend JP Morgan 32nd Annual Healthcare ConferenceBusiness Wire
Wednesday, January 8, 2014
ERBA Diagnostics, Inc. Exhibits at Arab Health 2014, Dubai, U.A.E.Business Wire
called 9/7/13 $1.02
Website
10-Q 8/12/14
Shares Outstanding: 43.88M
Float: 17.05M
100% Buy
Press Releases
Tuesday, August 12, 2014
ERBA Diagnostics Reports 2nd Quarter Financial Results; Consolidation, Operational Efficiencies, and Revenue Growth Increase Net Income by More Than 400%GlobeNewswire( (Tue, Aug 12)
Thursday, August 7, 2014
ERBA Diagnostics Schedules Conference Call to Discuss 2014 Second Quarter Financial ResultsGlobeNewswire
Monday, July 28, 2014
ERBA Diagnostics, Inc. to Exhibit at AACC 2014 in Chicago, USAGlobeNewswire
Friday, June 20, 2014
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and MarketingGlobeNewswire
Tuesday, May 27, 2014
ERBA Diagnostics, Inc. Appoints Mohan Gopalkrishnan as Chief Executive Officer and Prakash Patel as ControllerBusiness Wire
Wednesday, May 21, 2014
ERBA Diagnostics, Inc. Receives 510(K) Clearance for the XL200 Clinical Chemistry AnalyzerBusiness Wire
Thursday, May 15, 2014
ERBA Diagnostics, Inc. Reports First Quarter 2014 Financial ResultsBusiness Wire
Monday, April 14, 2014
ERBA Diagnostics, Inc. Reports 2013 Financial ResultsBusiness Wire
Thursday, April 10, 2014
ERBA Diagnostics, Inc. Announces Timeframe within Which It Intends to File Its Annual Report on Form 10-KBusiness Wire
Monday, March 31, 2014
ERBA Diagnostics, Inc. Announces Delay in Filing Annual Report on Form 10-KBusiness Wire
Wednesday, February 12, 2014
ERBA Diagnostics Inc. to Exhibit at Medlab Asia Pacific Singapore Feb 18-20, 2014Business Wire
Monday, January 13, 2014
ERBA Diagnostics, Inc. to Attend JP Morgan 32nd Annual Healthcare ConferenceBusiness Wire
Wednesday, January 8, 2014
ERBA Diagnostics, Inc. Exhibits at Arab Health 2014, Dubai, U.A.E.Business Wire
(0)
(0)